p-IgGen:一种配对抗体生成语言模型
Oliver M Turnbull1, Dino Oglic2, Rebecca Croasdale-Wood3
1Department of Statistics, University of Oxford, Oxford, OX1 3LB, United Kingdom.
Bioinformatics (Oxford, England)
|November 9, 2024
概括
我们开发了p-IgGen,一种蛋白质语言模型,用于生成新的抗体序列. 这种工具有助于克服抗体药物发现的挑战,通过设计具有改进的可开发性和生物物理性质的序列.
科学领域:
- 生物化学 生物化学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 抗体药物发现在设计具有最佳开发能力的序列方面面临挑战.
- 诸如聚合,多特异性,表达不良和溶解性低等问题阻碍了治疗性抗体的开发.
研究的目的:
- 介绍p-IgGen,一种用于配对重光链抗体生成的新型蛋白质语言模型.
- 开发一种微调的p-IgGen版本,用于产生具有理想3D生物物理性质的抗体.
主要方法:
- 利用蛋白质语言模型进行抗体序列生成.
- 在抗体序列数据上训练和微调p-IgGen模型.
- 对抗体样性质和生物物理特征进行评估的生成序列.
主要成果:
- p-IgGen产生多样化,类似抗体的序列,具有自然配对特性.
- 这种微调的模型倾向于产生具有临床阶段生物物理分布的抗体.
- 该模型解决了抗体设计中的关键可开发性挑战.
结论:
- p-IgGen为设计具有增强开发能力的新型抗体序列提供了强大的工具.
- 该模型有助于产生具有改善生物物理性质的治疗抗体.
- 这种方法有助于克服抗体药物发现中的关键障碍.
相关概念视频
Antibody Structure
59.1K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.1K
Antibody Structure and Classes
831
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
831
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K


